Treatment of the cells with cordycepin was able to modulate P-gp expression and inhibit its function by stimulating P-gp ATPase activity in cells stably expressing P-gp (ABCB1/Flp-InTM-293) and in cancer cells with a multidrug resistance profile (KB-vin). The gene discussed is DNAH8; the disease is cancer.